Hospital treatment of severe acute exacerbation of chronic obstructive pulmonary disease in COVID-19 situation: back to basics
Submitted: June 2, 2020
Accepted: July 31, 2020
Published: September 22, 2020
Accepted: July 31, 2020
Abstract Views: 1461
PDF: 965
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- G.G. Riario-Sforza, C. Incorvaia, F. Paterniti, N. Dugnani, M. Fumagalli, Different outcomes of pulmonary rehabilitation in patients with COPD with or without exacerbations , Monaldi Archives for Chest Disease: Vol. 63 No. 3 (2005): Pulmonary series
- Yaser Jenab, Marzieh Pourjafari, Maryam Sotoudeh, Masoumeh Lotfi-tokaldany, Nasrin Etesamifard, Shapour Shirani, Arash Jalali, Younes Nozari, Hamid-reza Poorhosseini, Comparing the effect of cardiac biomarkers on the outcome of normotensive patients with acute pulmonary embolism , Monaldi Archives for Chest Disease: Vol. 87 No. 1 (2017)
- Anna Stainer, Paola Faverio, Francesca Bono, Alberto Pesci, An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- Berardo Sarubbi, Gaetano Rea, Giuseppe Santoro, Enrico Melillo, Giancarlo Scognamiglio, Maria Giovannna Russo, Pulmonary veins stenosis relief after an inappropriate radiofrequency catheter ablation of atrial fibrillation in a young non-competitive athlete , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- Roberto Carlon, Mario Zanchetta, Is obesity still a coronary risk factor? , Monaldi Archives for Chest Disease: Vol. 68 No. 3 (2007): Cardiac series
- Claudio F. Donner, Sandro Amaducci, Elena Bacci, Sandra Baldacci, Maria L. Bartoli, Gianfranco M. Beghi, Alida Benfante, Sara Brighindi, Lucio Casali, Daniela Castiglia, Mario Cazzola, Alessandro Celi, Silvana Cianchetti, Giorgio Colombo, Claudia Crimi, Federico L. Dente, Giuseppe Di Maria, Annalisa Di Maria, Manuela Latorre, Federico Lavorini, Sara Maio, Claudia Mannini, Riccardo Messina, Pier Luigi Paggiaro, Patrizia Pignatti, David Price, Nicola Scichilone, Marzia Simoni, Antonio Spanevello, Martina Stagno d’Alcontres, Shawna Tan, Roberto Torchio, Giovanni Viegi, Dina Visca, Emiel F.M. Wouters, Shaylynn Yu Hui Xin, Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- G. Valli, P. Paoletti, D. Savi, D. Martolini, P. Palange, Clinical use of Heliox in Asthma and COPD , Monaldi Archives for Chest Disease: Vol. 67 No. 3 (2007): Pulmonary series
- Jayabharathi Palanivel, Madhusmita Mohanty Mohapatra, Manju Rajaram, Debasis Gochhait, Sunitha Vellathussery Chakkalakkoombil, Rakesh Singh, Exploring the role of Aspergillus galactomannan antigen in assessing the risk factor of acute exacerbations in chronic obstructive pulmonary disease patients: a cross-sectional study , Monaldi Archives for Chest Disease: Early Access
- M. Bartal, COPD and tobacco smoke , Monaldi Archives for Chest Disease: Vol. 63 No. 4 (2005): Pulmonary series
- E. Pozzi, Acebrophylline: an airway mucoregulator and anti-inflammatory agent , Monaldi Archives for Chest Disease: Vol. 67 No. 2 (2007): Pulmonary series
<< < 5 6 7 8 9 10 11 12 13 14 > >>
You may also start an advanced similarity search for this article.